SAPHRIS approved for pediatric manic or mixed bipolar I

Publisher： John Wiley & Sons Inc

E-ISSN： 1556-7567|17|7|8-8

ISSN： 1527-8395

Source： THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol.17, Iss.7, 2015-07, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Asenapine reduces manic and depressive episodes in maintenance trial for bipolar disorder

By  

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 29, Iss. 1, 2018-01 ,pp. : 1-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials

By Michalak E. E.   Guiraud-Diawara A.   Sapin C.  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 711-718

Informa Healthcare

Access to resources Recommend Favorite

Risk of recurrence after a single manic or mixed episode – a systematic review and meta‐analysis

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : 9-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accumulating Data and Dissipating Controversy in Pediatric Bipolar Disorder Research

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 17, Iss. S1, 2015-06 ,pp. : 23-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Depression Subtypes in Bipolar I and II Disorders

By  

Psychopathology, Vol. 41, Iss. 2, 2007-12 ,pp. : 111-114

Karger

Access to resources Recommend Favorite